首页/数据集/Characterization of the gut microbiome in HFrEF patients with AF treated with SGLT2i

Characterization of the gut microbiome in HFrEF patients with AF treated with SGLT2i

NIAID Data Ecosystem2026-05-02 收录

心血管疾病微生物组

肠道菌群营养干预

数据链接：

https://www.ncbi.nlm.nih.gov/sra/SRP572364 数据链接链接失效反馈

官方服务：

资源简介：

The structure and function of the gut microbiota in HFrEF patients and HFrEF patients with AF differ from that of healthy people. Even after SGLT2i treatment, their gut microbiota was still different.

应用场景：

创建时间：

2025-03-25

肠道菌群营养干预

代谢表型分析

Male C57BL/6J mice were fed a casein-based low fat (LF) diet or Western diets (WDs) containing a mixture of lean seafood (seafood WD) or lean meat (meat WD). Glucose and insulin tolerance tests were p

NIAID Data Ecosystem40

Additional file 6 of Intestinal microbiota and metabolome perturbations in ischemic and idiopathic dilated cardiomyopathy

心血管疾病微生物组

代谢物相关性

Additional file 6. Taxa_metabolite.spearman.corMatrix.

NIAID Data Ecosystem20

Sialylated milk glycans promote growth in gnotobiotic mice and pigs with a stunted Malawian infant gut microbiota. Sialylated glycans promote growth in gnotobiotic models

肠道菌群营养干预

婴儿生长迟缓模型

Identifying interventions that more effectively promote healthy growth of children with undernutrition is a pressing global health goal. Analysis of human milk oligosaccharides (HMOs) from 6-month pos

NIAID Data Ecosystem10

Supplementary Material for: Monosodium L-Glutamate and Dietary Fat Differently Modify the Composition of the Intestinal Microbiota in Growing Pigs

肠道菌群营养干预

膳食添加剂效应评估

Background: The Chinese have been undergone rapid transition to a high-fat diet-consuming lifestyle, while monosodium L-glutamate (MSG) is widely used as a daily food additive. It has been reported th

Figshare2017-06-20 更新30

Table_1_Emerging computational paradigms to address the complex role of gut microbial metabolism in cardiovascular diseases.DOCX

微生物代谢

心血管疾病微生物组

The human gut microbiota and its associated perturbations are implicated in a variety of cardiovascular diseases (CVDs). There is evidence that the structure and metabolic composition of the gut micro

NIAID Data Ecosystem10

Characterization of the gut microbiome in HFrEF patients with AF treated with SGLT2i

资源简介：

相关数据集